KBR Building Group Awarded Contract for Medicago’s Vaccine Research & Production Facility/Greenhouse in Research Triangle P...
November 11 2010 - 4:05PM
Business Wire
KBR (NYSE: KBR) today announced that its Building Group has been
awarded a contract by Alexandria Real Estate Equities for the
construction of Medicago’s new 90,000-square-foot Vaccine Research
and Production Facility/Greenhouse in Research Triangle Park,
N.C. The contract is valued at approximately $19 million. Site
work is underway.
Medicago’s plant-based commercial grade vaccines facility will
include an automated greenhouse, extensive laboratory, production
facility and office space with the project’s total investment
expected to exceed $32 million. Scheduled for completion in July
2011, the project is being managed from the Building Group’s
Raleigh office. The project has received substantial federal
funding from the Defense Advanced Research Projects Agency (DARPA)
through a $21 million research grant to improve the process of
producing large quantities of H1N1 vaccine.
“The Building Group is well known for its strong history in the
construction of advanced research and development facilities, with
an emphasis on vaccine production facilities,” said Luther
Cochrane, Senior Vice President, KBR and Chairman of the Building
Group. “I am confident that our team’s specialized expertise will
serve the Medicago project well and lead us to another successful
project completion in Research Triangle Park.”
KBR is a global engineering, construction and services company
supporting the energy, hydrocarbon, government services, minerals,
civil infrastructure, power and industrial markets. For more
information, visit www.kbr.com.
KBR (NYSE:KBR)
Historical Stock Chart
From Apr 2024 to May 2024
KBR (NYSE:KBR)
Historical Stock Chart
From May 2023 to May 2024